2026–27 Psychopharmacology Updates
Boost Your Psychopharmacology Skills and Earn CMEs
Save time and earn up to 155 CMEs, including 40 SA CME credits
Practical Tips
Nuggets of clinical wisdom you can apply to patient care today.
More CMEs Than You Need
Earn up to 155 CMEs, and 40 SA CMEs.
Choose Your Learning Style
Audio, text, and video.
Forget About Commercial Bias
No industry funding, guaranteed.
Forget Boring CMEs: Choose Your Own Style
Earn up to 155 CMEs and 40 SA CMEs.
Read, listen, or watch bite-sized videos.
More than 2 hours of monthly psychopharm updates, plus instant access to our archive of more than 90 hours.
Video Lectures: Learning, Reimagined
Bronze, Silver, and Gold Memberships
Bite-sized videos to update your prescribing skills. Includes key points summarizing the most practical tips.
Lithium Guide to Dosage, Monitoring, and Patient Education
David Osser, M.D.
Harvard Medical School
Expert Consultations: Real-World Answers
We interview experts who share clinical pearls for your busy practice.
Use of MAOI in clinical practice – Interview
Ken Gillman, M.D.
PsychoTropical Research
Helen Tellegen, P.M.H.N.P.
San Antonio State Hospital
See the list of video lectures available for instant access
Brian Miller, M.D., Ph.D., M.P.H.
Professor of Psychiatry at Medical College of Georgia Augusta University
Paul S. Links, M.D., F.R.C.P.C.
Professor Emeritus in the Department of Psychiatry and Behavioural Neurosciences at McMaster University in Hamilton, Ontario, Canada
Scott R. Beach, M.D.
Associate Professor of Psychiatry at Harvard Medical School
Quick Takes: Research, Digested
Five research summaries in adult psychiatry, each month.
Lumateperone for Depression with Mixed Features: Is It Effective?
Kristin Raj, M.D.
Stanford School of Medicine
Brain Guides: Better Prescribing
Concise, practical guides to prescribing with confidence.
Ketamine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
This guide provides a comprehensive overview of ketamine for psychiatric use, covering its rapid antidepressant mechanisms, off-label applications in treatment-resistant depression and suicidality, dosing protocols, pharmacokinetics, drug interactions, adverse effects, and special population considerations.
Sebastián Malleza, M.D.
Psychopharmacology Institute
Quick Takes for instant access
See the list of upcoming Quick Takes 2026-27
Quick Take Vol. 104
Quick Take Vol. 103
Quick Take Vol. 102
Quick Take Vol. 101
Quick Take Vol. 100
Quick Take Vol. 99
Quick Take Vol. 98
Quick Take Vol. 97
Quick Take Vol. 96
Quick Take Vol. 95
Quick Take Vol. 94
Listen to All Our Website Content on an Audio Feed
Download any episode of our subscription content on your favorite podcasting app, and earn CMEs.
Here’s how:
1. Download episodes from your audio feed.
2. Earn CMEs by logging into our website.
Access 4 times more content than with our open podcast.
See our upcoming updates for 2026-2027
Brexpiprazole Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Management of Complex ADHD – Interview
Quick Take Vol. 94
Pharmacotherapy for Cannabis Use Disorder
Aripiprazole Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Quick Take Vol. 95
Citalopram and Escitalopram: A Summary of Key Differences and Similarities (2026 Update)
The Psychopharmacology Algorithm for Psychotic Depression
Lithium Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects
Quick Take Vol. 96
CME Information
Physicians – CME Accreditation Statement
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing professionals – CME Accreditation Statement
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The ANCC accepts AMA PRA Category 1 Credit(s)™ as Contact Hours, under this calculation: 1 CME = 1 Contact Hour.
All of our content is psychopharmacology, so the pharmacology hours shown on your certificate match the credits awarded for that activity. Your certificate states them on their own line, separately from the credit designation statement.
This applies to APRN pharmacology renewal as well. Boards of nursing define pharmacology CE in their own way, so please confirm with your board that this is the documentation they expect.
Physician assistants – CME Accreditation Statement
The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medical Academy, LLC designates each enduring material for the number of AMA PRA Category 1 Credits™ listed below. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The NCCPA accepts AMA PRA Category 1 Credit™ from providers accredited by the ACCME toward PA certification maintenance. Requirements are set by the NCCPA, so please confirm with them what your current cycle requires.
Physicians outside the United States – CME Accreditation Statement
AMA PRA Category 1 Credit™ may be awarded to any physician, whether or not they are licensed in the United States. The requirements are the same.
The American Medical Association has an agreement of mutual recognition of Continuing Medical Education (CME) credits with the European Union of Medical Specialists (UEMS), the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMEC®s) should contact the UEMS at mutualrecognition@uems.eu.
Whether these credits count toward your own national continuing education requirement is decided by your national medical chamber or society, and the rules differ from country to country. We recommend confirming with them before relying on the credits for a licensing or recertification requirement.
Self Assessment for MOC – Accreditation Statement
- Psychopharmacology Institute Self-Assessment Program 2026
Dates: April 1, 2026 – April 1, 2029
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2026 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.
- Psychopharmacology Institute Self-Assessment Program 2025
Dates: April 1, 2025 – April 1, 2028
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2025 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.
- Psychopharmacology Institute Self-Assessment Program 2024
Dates: April 1, 2024 – April 1, 2027
The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2024 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.
Our faculty: Experts with practical
experience
James Phelps, M.D.
Psychiatrist Emeritus
Samaritan Mental Health, Corvallis, Oregon
David Osser, M.D.
Associate Professor of Psychiatry
Harvard Medical School
Scott R. Beach, M.D.
Associate Professor of Psychiatry
Harvard Medical School
Robert Hudak, M.D.
Professor of Psychiatry
University of Pittsburgh
Amanda Koire, M.D., Ph.D.
Attending Psychiatrist & Assistant Professor of Psychiatry
Brigham and Women's Hospital – Harvard Medical School
Oliver Freudenreich, M.D., F.A.C.L.P.
Co-director of the MGH Psychosis Clinical and Research Program & Professor of Clinical Psychiatry
Massachusetts General Hospital – Harvard Medical School
Chris Aiken, M.D.
Assistant Professor of Psychiatry
NYU and WFU Schools of Medicine – Carlat Psychiatry Report
Brian Miller, M.D., Ph.D., M.P.H.
Professor of Psychiatry
Medical College of Georgia Augusta University
Anita H. Clayton, M.D., D.L.F.A.P.A., I.F.
Wilford W. Spradlin Professor and Chair of Psychiatry
University of Virginia School of Medicine, Charlottesville, VA
What clinicians are saying
it is nice to have updated information regarding pharmacologic treatments available in one place. the tutorials are concise, yet full of necessary information.
Claudia Cuervo, M.D.
Your algorithms are a great resource for teaching and consulting
Matthew Goodwin, M.D.